{"pageContent": "Objective: \u2022To determine if the prostate-specific antigen (PSA) nadir after high-intensity focused ultrasound (HIFU) can be used as a predictor of the biochemical disease-free survival rate (DFSR).", "metaData": {"source": "Does MRI-guided TULSA provide a targeted approach to ablation?\nhttps://pubmed.ncbi.nlm.nih.gov/33244176/"}}